Cargando…

Reversible splenial lesion syndrome in neuroleptic malignant syndrome

BACKGROUND: Reversible focal lesions in the splenium of the corpus callosum (SCC) or reversible splenial lesion syndrome are rare and little is known about their pathophysiology. CASE SUMMARY: The authors describe a case of a 65-year-old female who presented with fever, abnormal behaviour and mild h...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Edrus, SA, Norzaini, R, Chua, R, Puvanarajah, SD, Shuguna, M, Muda, S
Formato: Texto
Lenguaje:English
Publicado: Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Malaysia 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097717/
https://www.ncbi.nlm.nih.gov/pubmed/21610992
http://dx.doi.org/10.2349/biij.5.4.e24
_version_ 1782203875473752064
author Al-Edrus, SA
Norzaini, R
Chua, R
Puvanarajah, SD
Shuguna, M
Muda, S
author_facet Al-Edrus, SA
Norzaini, R
Chua, R
Puvanarajah, SD
Shuguna, M
Muda, S
author_sort Al-Edrus, SA
collection PubMed
description BACKGROUND: Reversible focal lesions in the splenium of the corpus callosum (SCC) or reversible splenial lesion syndrome are rare and little is known about their pathophysiology. CASE SUMMARY: The authors describe a case of a 65-year-old female who presented with fever, abnormal behaviour and mild hypernatremia. She was on neuropsychiatric treatment for bipolar disorder but denied any history of seizure. After an extensive workout to exclude infection, a clinical diagnosis of neuroleptic malignant syndrome (NMS) was made. Initial magnetic resonance imaging (MRI) of the brain showed a lesion in the SCC characterized by high-signal intensity on T2-weighted and FLAIR sequences with reduced signal intensity on T1-weighted sequence. Diffuse weighted imaging (DWI) showed restricted diffusion. There was no enhancement following Gadolinium administration. The follow-up MRI 8 weeks later showed complete resolution of the SCC lesion. CONCLUSION: While the pathophysiology of reversible SCC lesions is still unclear, this case highlights the need to consider NMS in the differential diagnosis of reversible splenial lesion of the corpus callosum.
format Text
id pubmed-3097717
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Malaysia
record_format MEDLINE/PubMed
spelling pubmed-30977172011-05-24 Reversible splenial lesion syndrome in neuroleptic malignant syndrome Al-Edrus, SA Norzaini, R Chua, R Puvanarajah, SD Shuguna, M Muda, S Biomed Imaging Interv J Case Report BACKGROUND: Reversible focal lesions in the splenium of the corpus callosum (SCC) or reversible splenial lesion syndrome are rare and little is known about their pathophysiology. CASE SUMMARY: The authors describe a case of a 65-year-old female who presented with fever, abnormal behaviour and mild hypernatremia. She was on neuropsychiatric treatment for bipolar disorder but denied any history of seizure. After an extensive workout to exclude infection, a clinical diagnosis of neuroleptic malignant syndrome (NMS) was made. Initial magnetic resonance imaging (MRI) of the brain showed a lesion in the SCC characterized by high-signal intensity on T2-weighted and FLAIR sequences with reduced signal intensity on T1-weighted sequence. Diffuse weighted imaging (DWI) showed restricted diffusion. There was no enhancement following Gadolinium administration. The follow-up MRI 8 weeks later showed complete resolution of the SCC lesion. CONCLUSION: While the pathophysiology of reversible SCC lesions is still unclear, this case highlights the need to consider NMS in the differential diagnosis of reversible splenial lesion of the corpus callosum. Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Malaysia 2009-10-01 /pmc/articles/PMC3097717/ /pubmed/21610992 http://dx.doi.org/10.2349/biij.5.4.e24 Text en © 2009 Biomedical Imaging and Intervention Journal http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Al-Edrus, SA
Norzaini, R
Chua, R
Puvanarajah, SD
Shuguna, M
Muda, S
Reversible splenial lesion syndrome in neuroleptic malignant syndrome
title Reversible splenial lesion syndrome in neuroleptic malignant syndrome
title_full Reversible splenial lesion syndrome in neuroleptic malignant syndrome
title_fullStr Reversible splenial lesion syndrome in neuroleptic malignant syndrome
title_full_unstemmed Reversible splenial lesion syndrome in neuroleptic malignant syndrome
title_short Reversible splenial lesion syndrome in neuroleptic malignant syndrome
title_sort reversible splenial lesion syndrome in neuroleptic malignant syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097717/
https://www.ncbi.nlm.nih.gov/pubmed/21610992
http://dx.doi.org/10.2349/biij.5.4.e24
work_keys_str_mv AT aledrussa reversiblespleniallesionsyndromeinneurolepticmalignantsyndrome
AT norzainir reversiblespleniallesionsyndromeinneurolepticmalignantsyndrome
AT chuar reversiblespleniallesionsyndromeinneurolepticmalignantsyndrome
AT puvanarajahsd reversiblespleniallesionsyndromeinneurolepticmalignantsyndrome
AT shugunam reversiblespleniallesionsyndromeinneurolepticmalignantsyndrome
AT mudas reversiblespleniallesionsyndromeinneurolepticmalignantsyndrome